Monday, October 31, 2022
Govt Job: For M.Pharm, MSc at RARI, Ministry of AYUSH
The Central Council for Research Institute, Kothrud, Pune,
https://thehealthmaster.com/2022/10/30/govt-job-for-m-pharm-msc-at-rari-ministry-of-ayush/
Sunday, October 30, 2022
KOCHI: Stroke causes six times more deaths in people than C-19 does. But then, it’s hardly talked about.
Consistent with the worldwide Burden of Disease study, India reports 1.29 million new stroke cases annually.
It's also the third-largest explanation for deaths and disability in India, consistent with the study which was recently released.
“One in six individuals carries the danger of facing a stroke. So, we should always remember the symptoms.
It's crucial to recollect that in select cases, stroke is often treated efficiently through intravenous thrombolysis and mechanical thrombectomy with excellent chances of recovery,” says dr Mounil Haq T P, consultant interventional neurologist at E M S Memorial Cooperative Hospital and Research Centre, Kerala.
One of the foremost critical factors to think about during stroke treatment is the time taken to urge the affected person to a hospital.
Normally, doctors suggest patients be delivered to the hospital within 3.5 hours of symptoms surfacing.
Moreover, the absence of ordinary treatment protocols and therefore the lack of affordable treatment adds to the burden.
Delay in seeking the proper treatment results in a loss of about 20 lakh brain cells per minute.
This is often where advanced technology and medical procedures like mechanical thrombectomy have displayed proven results and better success rates.
Not only do they increase the treatment window to up to 24 hours, but the success rates also are considered to be one of the simplest.
Also read | Telemedicine and MTP
What is Mechanical Thrombectomy
Mechanical thrombectomy may be a sort of minimally invasive procedure during which specialized medical devices like stent retrievers and catheters are used to remove a clot from a patient’s artery within the brain.
Using CathLab guidance, the doctor guides these devices through the patient’s arteries to the clot, extracting the clot.
But the technology is being adopted slowly. So far, only 10% of the 11,000 patients treated for acute ischaemic stroke in India have have had have received mechanical thrombectomy as a treatment option.
“Mechanical thrombectomy is extremely effective in revascularization, successful in almost 95 percent of cases, and facilitates clinical recovery in 60 percent of patients,” Haq said.
Types of stroke
The most common sort of stroke is ischemic, accounting for nearly 87% of all cases across the country.
It's caused by a clot or other blockage to a brain artery.
The remaining 13% of cases are hemorrhagic strokes which are caused by bleeding of an aneurysm within the brain artery.
Doctors and doctors largely attribute the high prevalence and morbidity rates to the shortage of awareness amongst the overall population alongside limited exposure and knowledge about new technologies like Mechanical Thrombectomy to scale back the morbidity rates.
https://thehealthmaster.com/2020/11/11/stroke-treatment-new-scope/
Medical Stores पर कार्रवाई: नशीली दवाई बेचने पर Licenses cancel, suspend
Saturday, October 29, 2022
Medical Stores पर कार्रवाई: नशीली दवाई बेचने पर Licenses cancel, suspend
Contractual Staff Under PM Ayushman Bharat Health Infrastructure Mission (PM-ABHIM), U.T., Chandigarh, Health & Family Welfare Department, National Health Mission, Pharmacist jobs in 2022, Pharmacy recruitment at Chandigarh, Pharmacy vacancies, Pharma jobs
Post: Pharmacist under PM- ABHIM
No of Posts: 13 posts (Gen-09, SC-01, OBC-03)
EssentialD-Pharma/ Bachelor Degree in Pharmacy from a recognized University With One year Diploma in Computer Applications Should be Registered as a Pharmacist with U.T, Chandigarh Pharmacy Council
Consolidated Amount In Rs. (per month): 16,377Applications are invited to fill up the following posts in O/o Mission Director, National Health Mission, 4th Floor, Administrative Block, Sector-16, U.T., Chandigarh:
Terms & Conditions:-The age limit for the above-mentioned category is up to 60 years
Last date of receipt of Applications: 02.11.2022 up to 1.00 pm
ist of Eligible candidates and the date of the written test will be displayed in O/o Mission Director, National Health Mission, 4th Floor, Administrative Block, GMSH, Sector-16, Chd: 11.11.2022
Criteria of Selection:Written test: 90 Marks
Experience: 10 Marks for the candidates who have worked in COVID-19 between 1st April 2020 to 31st March 2022 in GMCH-32 or/and GMSH-16, Chd & it's allied health facilities.
These candidates will be given marks as follows: Worked for More than 6 months - 10 marks Worked for 3 months to 6 months - 05 marks Worked for Less than 3 months - 00 marks
These posts are to be filled initially on a contract basis up to 31.03.2023 but extendable depending upon performance and conduct, etc., or duration of the project.
Desirous candidates having the requisite qualifications mentioned above shall submit their Bio-data in Application Format (available on the website) along with self-attested photocopies of certificates/testimonials (from matriculation onwards) and one recent passport size photograph duly attested by Gazetted Officer to the O/o Mission Director, National Health Mission, 4th Floor, Administrative Block, Govt. Multi Speciality Hospital, Sector-16, Chd.
Incomplete applications and applications received after the due date will not be entertained.
The claim of the candidates to SC/OBC (not BC) categories will be considered only when accompanied by the certificate issued by the competent authority in the prescribed format.
Only those OBC category candidates will be considered, whose caste is falling under the OBC category of State List, U.T, Chandigarh vide the following notification no. issued by Social Welfare Department, Chandigarh Administration:
- F-III-SW-127/SW/OBC/95/1245 dated 27.06.1995,
- F3/SW/OBC/2001/2272 dated 03.09.2001,
- No.F3/SW/OBC/2004/443-445 dated 05.02.2004
- SW/OBC/2015/ 2951 dated 26.03.2015
The Mission Director, NHM reserves the right to increase or decrease the number of vacancies and even cancel the written test without assigning any reason.
No TA/DA will be paid for the written test.
Last date of receipt of Applications: 02.11.2022 up to 1.00 pm
Application Form >>
Govt Job: For M.Pharm or M.Sc as Junior Research Fellow at...
Govt Job: For the post of Pharmacists at ITBP
Govt Job: For Pharmacy, Life Sciences candidates at PBTI – Pay Rs. 67,400 pm
Govt Job: Applications are invited for post of JRF at ICMR-NARI
Govt Job: For M.Pharm under Ministry of Health and Family Welfare
Govt Job: For Pharmacist under Public Service Commission
https://thehealthmaster.com/2022/10/29/govt-job-for-pharmacists-at-health-family-welfare-department/
The US Food and Drug Administration (USFDA) has given the final approval to Alembic Pharma’s Paclitaxel injection USP, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 mL (6 mg/mL), and 300 mg/50 mL (6 mg/mL) multiple-dose vials, a statement from Alembic pharma notified yesterday.
According to the statement, this is the first product approval for oncology injection from our F-2 Facility (oncology injectable) which recently completed the first USFDA inspection.
Further, the statement said that the approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Taxol injection, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 mL (6 mg/mL), and 300 mg/50 mL (6 mg/mL).
Click for more on USFDA
Paclitaxel injection is indicated as subsequent therapy for the treatment of advanced carcinoma of the ovary.
As first-line therapy, it is indicated in combination with cisplatin for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy, added the statement.
Click for more on Alembic Pharma
In the clinical trial, there was an overall favorable effect on disease-free and overall survival in the total population of patients with receptor-positive and receptor-negative tumors, but the benefit has been specifically demonstrated by available data (median follow-up 30 months) only in the patients with estrogen and progesterone receptor-negative tumors.
Paclitaxel injection has an estimated market size of $26 million for 12 months ending June 2022, according to IQVIA, the statement concluded.
Other drugs approval by USFDA
USFDA gives approval to this Blood Cancer therapy
USFDA grants final approval for Micafungin for injection
USFDA gives tentative approval for Valbenazine capsules
USFDA gives nod for Extended Phenytoin Sodium Capsules
USFDA gives final approval for Brivaracetam tablets
This State Pharmacy Council to appoint Pharmacy Inspectors
Medical Stores पर कार्रवाई: नशीली दवाई बेचने पर Licenses cancel, suspend
Two persons arrested in fake BP medicine racket
NPPA extends time limit for submission of data of Drugs & Medical Devices
USFDA gives approval to this Blood Cancer therapy
NPPA fixes retail price for diabetes drug combination Dapagliflozin & Sitagliptin
USFDA grants final approval for Micafungin for injection
DTAB ratifies Rule 46 of Medical Devices Rules, 2017
Dove shampoos recalled due to this reason
Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/10/29/usfda-gives-final-approval-for-paclitaxel-injection/
Medical Stores पर कार्रवाई: नशीली दवाई बेचने पर Licenses cancel, suspend
Friday, October 28, 2022
Download: NPPA / DPCO - Latest notifications
The Govt. of India issues notifications from time to time which are published by the Department of Publication and are printed by the Government of India Printing Presses regularly.
We have provided some of the notifications relevant to the above-said topic, Click the below links for more information:
Latest Notifications..
2022
O.M. dt 21-10-2022 Extension of the last date for filing statutory forms prescribed under DPCO, 2013
O.M.-dt-21-10-2022-Extension-of-last-date-for-filing-statutory-forms-prescribed-under-DPCO-2013
S.O. 4595(E) dt 29-09-2022 Extension Revised ceiling price of Dextrose Injection in 100ml pack having special features under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4595E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4594(E) dt 29-09-2022 Extension Revised ceiling price of Mannitol Injection 20% in 100ml pack having special features under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4594E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Mannitol-Injection-20-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4593(E) dt 29-09-2022 Extension Revised ceiling price of Metronidazole Injection IP in 100ml pack having special features under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4593E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4592(E) dt 29-09-2022 Extension of revised ceiling price of Ringer Lactate Injection having special features under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4592E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-Ringer-Lactate-Injection-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4591(E) dt 29-09-2022 Extension of revised ceiling price of IV Fluid Injection having special features under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4591E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-IV-Fluid-Injection-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4590(E) dt 29-09-2022 Extension of revised price of Liquid Medical Oxygen (LMO) and Oxygen Inhalation (Medicinal Gas) in cylinder under Drugs (Prices Control) Order, 2013 based on the decision of Authority meeting dated 27
S.O.-4590E-dt-29-09-2022-Extension-of-revised-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-Authority-meeting-dated-27
S.O. 4589(E) dt 29-09-2022 Extension of revised ceiling price of Heparin Injection under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4589E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4588(E) dt 29-09-2022 NPPA has fixed retail prices of 40 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022
S.O.-4588E-dt-29-09-2022-NPPA-has-fixed-retail-prices-of-40-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4343(E) dt 15-09-2022 Notification regarding extension of Knee implants under Drugs (Prices Control) Order, 2013.
S.O.-4343E-dt-15-09-2022-Notification-regarding-extension-of-Knee-implants-under-Drugs-Prices-Control-Order-2013.
S.O. 4342(E) dt 15-09-2022 NPPA has fixed retail prices of 1 formulation under Drugs (Prices Control) Order, 2013 (WPA) based on the decision of 101st Authority meeting dated 07.09.2022.
S.O.-4342E-dt-15-09-2022-NPPA-has-fixed-retail-prices-of-1-formulation-under-Drugs-Prices-Control-Order-2013-WPA-based-on-the-decision-of-101st-Authority-meeting-dated-07.09.2022.
S.O. 4341(E) dt 15-09-2022 NPPA has fixed retail prices of 36 formulations under the Drugs (Prices Control) Order, 2013 based on the decision of the 101st Authority meeting dated 07.09.2022.
S.O.-4341E-dt-15-09-2022-NPPA-has-fixed-retail-prices-of-36-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-101st-Authority-meeting-dated-07.09.2022.
OM dated 25.08.2022 relating to fixation of Ceiling Price of Sodium Chloride 0.45% Injection.
OM-dated-25.08.2022-relating-to-fixation-of-Ceiling-Price-of-Sodium-Chloride-0.45-Injection.
S.O. 4002(E) dt 24-08-2022 NPPA has fixed retail prices of 45 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 100th Authority meeting dated 05.08.2022.
S.O.-4002E-dt-24-08-2022-NPPA-has-fixed-retail-prices-of-45-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-100th-Authority-meeting-dated-05.08.2022.
S.O. dt 29-07-2022 Notification regarding extension of capping of trade margin of 5 Medical Devices
S.O.-dt-29-07-2022-Notification-regarding-extension-of-capping-of-trade-margin-of-5-Medical-Devices
S.O. 2983(E) dt 30-06-2022 Notification regarding extension of price regulation on Oxygen Concentrator
S.O.-2983E-dt-30-06-2022-Notification-regarding-extension-of-price-regulation-on-Oxygen-Concentrator
S.O. 2982(E) dt 30-06-2022 Notification regarding extension of price regulation on LMO and Oxygen Inhalation
S.O.-2982E-dt-30-06-2022-Notification-regarding-extension-of-price-regulation-on-LMO-and-Oxygen-Inhalation
S.O. 2981(E) dt 30-06-2022 NPPA has fixed the retail prices of 84 new drugs based on the decision taken in 99th Authority meeting dated 28.06.2022
S.O.-2981E-dt-30-06-2022-NPPA-has-fixed-the-retail-prices-of-84-new-drugs-based-on-the-decision-taken-in-99th-Authority-meeting-dated-28.06.2022
S.O. 2465(E) dt 30-05-2022 Notification regarding extension of TMR notification on Oxygen Concentrators
S.O.-2465E-dt-30-05-2022-Notification-regarding-extension-of-TMR-notification-on-Oxygen-Concentrators
S.O. 2166 (E) DT 09-05-2022 NPPA has revised retail price of 1 formulation under Drugs (Prices Control) Order, 2013 based on review order.
S.O.-2166-E-DT-09-05-2022-NPPA-has-revised-retail-price-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-review-order.
S.O. 2165(E) Dt 09-05-2022 NPPA has fixed retail prices of 18 formulations under Drugs (Prices Control) Order, 2013 the price of which were applied earlier in the 96th Authority meeting dated 24.03.2022.
S.O.-2165E-Dt-09-05-2022-NPPA-has-fixed-retail-prices-of-18-formulations-under-Drugs-Prices-Control-Order-2013-the-price-of-which-were-applied-earlier-in-the-96th-Authority-meeting-dated-24.03.2022.
S.O. 2164(E) Dt 09-04-2022 NPPA has fixed retail prices of 66 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 97th Authority meeting dated 06.05.2022.
S.O.-2164E-Dt-09-04-2022-NPPA-has-fixed-retail-prices-of-66-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-97th-Authority-meeting-dated-06.05.2022.
S.O. 1833(E) dt 18-04-2022 NPPA has fixed retail prices of 15 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 96th Authority meeting dated 24.03.2022
S.O.-1833E-dt-18-04-2022-NPPA-has-fixed-retail-prices-of-15-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-96th-Authority-meeting-dated-24.03.2022
S.O. 1782(E) dt 12-04-2022 NPPA has fixed retail prices of 23 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 96th Authority meeting dated 24.03.2022
S.O.-1782E-dt-12-04-2022-NPPA-has-fixed-retail-prices-of-23-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-96th-Authority-meeting-dated-24.03.2022
S.O. 1508(E) dt 30-03-2022 NPPA has fixed ceiling prices of Liquid Medical Oxygen, Medical Inhalation under Drugs (Prices Control) Order, 2013
S.O.-1508E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Liquid-Medical-Oxygen-Medical-Inhalation-under-Drugs-Prices-Control-Order-2013
S.O. 1507(E) dt 30-03-2022 NPPA has fixed ceiling prices of Heparin Injection under Drugs (Prices Control) Order, 2013
S.O.-1507E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013
S.O. 1506(E) dt 30-03-2022 NPPA has fixed ceiling prices of Dextrose under Drugs (Prices Control) Order, 2013
S.O.-1506E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Dextrose-under-Drugs-Prices-Control-Order-2013
S.O. 1505(E) dt 30-03-2022 NPPA has fixed ceiling prices of Mannitol under Drugs (Prices Control) Order, 2013
S.O.-1505E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Mannitol-under-Drugs-Prices-Control-Order-2013
S.O. 1504(E) dt 30-03-2022 NPPA has fixed ceiling prices of Metronidazole under Drugs (Prices Control) Order, 2013
S.O.-1504E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Metronidazole-under-Drugs-Prices-Control-Order-2013
S.O. 1503(E) dt 30-03-2022 NPPA has fixed ceiling prices of 9 formulations under Drugs (Prices Control) Order, 2013
S.O.-1503E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-9-formulations-under-Drugs-Prices-Control-Order-2013
S.O. 1502(E) dt 30-03-2022 NPPA has fixed ceiling prices of 2 Coronary stents under Drugs (Prices Control) Order, 2013
S.O.-1502E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-2-Coronary-stents-under-Drugs-Prices-Control-Order-2013
S.O. 1501(E) dt 30-03-2022 NPPA has fixed ceiling prices of 4 formulations under Drugs (Prices Control) Order, 2013
S.O.-1501E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-4-formulations-under-Drugs-Prices-Control-Order-2013
S.O. 1500(E) dt 30-03-2022 NPPA has fixed ceiling prices of 8 formulations under Drugs (Prices Control) Order, 2013
S.O.-1500E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-8-formulations-under-Drugs-Prices-Control-Order-2013
S.O. 1499(E) dt 30-03-2022 NPPA has fixed ceiling prices of 872 formulations under Drugs (Prices Control) Order, 2013
S.O.-1499E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-872-formulations-under-Drugs-Prices-Control-Order-2013
OM. dt 25-03-2022 Movement in Wholesale Price Index (WPI) for the preceding calendar year 2021
OM.-dt-25-03-2022-Movement-in-Wholesale-Price-Index-WPI-for-the-preceding-calendar-year-2021
S.O. 796(E) dt 18-02-2022 NPPA has fixed ceiling prices of 19 formulations under Drugs (Prices Control) Order, 2013
S.O.-796E-dt-18-02-2022-NPPA-has-fixed-ceiling-prices-of-19-formulations-under-Drugs-Prices-Control-Order-2013
S.O. 401(E) dt 31-01-2022 Extension of Trade Margin Rationalization on 5 Medical Devices, namely, Pulse Oximeter, Blood Pressure Monitoring Machine, Nebulizer, Digital Thermometer, and Glucometer
S.O.-401E-dt-31-01-2022-Extension-of-Trade-Margin-Rationalization-on-5-Medical-Devices-namely-Pulse-Oximeter-Blood-Pressure-Monitoring-Machine-Nebulizer-Digital-Thermometer-and-Glucometer
2021
S.O. 5428(E) dt 28-12-2021 Extension Revised ceiling price of Dextrose Injection in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5428E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 5427(E) dt 28-12-2021 Extension Revised ceiling price of Mannitol Injection in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5427E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Mannitol-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 5426(E) dt 28-12-2021 Extension Revised ceiling price of Metronidazole Injection IP in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5426E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 5425(E) dt 28-12-2021 NPPA has fixed ceiling prices of 2 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5425E-dt-28-12-2021-NPPA-has-fixed-ceiling-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 5424(E) dt 28-12-2021 Extension of price of Liquid Medical Oxygen (LMO) and Oxygen Inhalation (Medicinal Gas) in cylinder under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5424E-dt-28-12-2021-Extension-of-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 5423(E) dt 28-12-2021 - NPPA has fixed retail prices of 28 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5423E-dt-28-12-2021-NPPA-has-fixed-retail-prices-of-28-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 4885(E) dt 26-11-2021 NPPA has fixed ceiling prices of 2 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 93rd Authority meeting dated 15.11.2021.
S.O.-4885E-dt-26-11-2021-NPPA-has-fixed-ceiling-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-93rd-Authority-meeting-dated-15.11.2021.
S.O. 4884(E) dt 26-11-2021 NPPA has fixed retail prices of 47 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 93rd Authority meeting dated 15.11.2021.
S.O.-4884E-dt-26-11-2021-NPPA-has-fixed-retail-prices-of-47-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-93rd-Authority-meeting-dated-15.11.2021.
OM dt 22-11-2021- on Paragraph 28 of DPCO, 2013 regarding refusal to sell drugs by manufacturers
OM-dt-22-11-2021-on-Paragraph-28-of-DPCO-2013-regarding-refusal-to-sell-drugs-by-manufacturers
S.O. 4241(E) dt 12-10-2021 - Addendum to S. O. 3934(E) dated 23.09.2021 - Methotrexate Topical Gel
S.O.-4241E-dt-12-10-2021-Addendum-to-S.-O.-3934E-dated-23.09.2021-Methotrexate-Topical-Gel
NPPA OM dt 30-09-2021 increase in GST rate - Medical Devices
NPPA-OM-dt-30-09-2021-increase-in-GST-rate-Medical-Devices
S.O. 3939(E) dt 23-09-2021 - Revised ceiling price of Dextrose Injection in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-3939E-dt-23-09-2021-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O. 3938(E) dt 23-09-2021 - Revised ceiling price of Mannitol Injection 20% in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-3938E-dt-23-09-2021-Revised-ceiling-price-of-Mannitol-Injection-20-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O. 3937(E) dt 23-09-2021 - Revised ceiling price of Metronidazole Injection IP in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-3937E-dt-23-09-2021-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
Click for more articles on NPPA / DPCO
S.O. 3936(E) dt 23-09-2021 - Extension of price of Liquid Medical Oxygen (LMO) and Oxygen Inhalation (Medicinal Gas) in cylinder under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-3936E-dt-23-09-2021-Extension-of-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O. 3934(E) dt 23-09-2021 - NPPA has fixed retail prices of 23 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-3934E-dt-23-09-2021-NPPA-has-fixed-retail-prices-of-23-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O. (E) dt 23-09-2021 - Extension of revised ceiling price of Heparin Injection under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-E-dt-23-09-2021-Extension-of-revised-ceiling-price-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O 3783(E) dt 15-09-2021 - NPPA has revised retail prices of 1 formulation under Drugs (Prices Control) Order, 2013 based on the decision of 91st Authority meeting dated 29.07.2021.
S.O-3783E-dt-15-09-2021-NPPA-has-revised-retail-prices-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021.
S.O. 3670(E) dt 10-09-2021 Regarding ceiling price fixation or revision of Orthopaedic Knee Implants for Knee Replacement System
S.O.-3670E-dt-10-09-2021-Regarding-ceiling-price-fixation-or-revision-of-Orthopaedic-Knee-Implants-for-Knee-Replacement-System
S.O. 3400(E) dt 19-08-2021 - NPPA has fixed retail prices of 19 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 91st Authority meeting dated 29.07.2021
S.O.-3400E-dt-19-08-2021-NPPA-has-fixed-retail-prices-of-19-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021
S.O. 3249(E) dt 12-08-2021 - Amendment in paragraph 18 of DPCO, 2013
S.O.-3249E-dt-12-08-2021-Amendment-in-paragraph-18-of-DPCO-2013
S.O 3162(E) dt 06-08-2021 - NPPA has fixed retail prices of 6 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 91st Authority meeting dated 29.07.2021
S.O-3162E-dt-06-08-2021-NPPA-has-fixed-retail-prices-of-6-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021
NPPA Office Memorandum 03-08-2021 - Submission of price related information for Knee Implants.
NPPA-Office-Memorandum-03-08-2021-Submission-of-price-related-information-for-Knee-Implants.
NPPA Office Memorandum dt 23-07-2021 – for Revised MRPs in pursuance to the TMR Notification for 5 Medical Devices
NPPA-Office-Memorandum-dt-23-07-2021-–-for-Revised-MRPs-in-pursuance-to-the-TMR-Notification-for-5-Medical-Devices
S.O. 2899(E) dt 20-07-2021 Order on Amendment in the Drugs (Prices Control) Order, 2013 for inclusion on Form VI
S.O.-2899E-dt-20-07-2021-Order-on-Amendment-in-the-Drugs-Prices-Control-Order-2013-for-inclusion-on-Form-VI
S.O. 2820(E) dt 14-07-2021 NPPA has fixed retail prices of 14 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 89th Authority meeting dated 28.06.2021
S.O.
https://thehealthmaster.com/notifications/nppa-dpco-notifications/
Govt Job: For the post of Pharmacists at ITBP
The Indo-Tibetan Border Police are India's primary border patrol organization for its border with China's Tibet Autonomous Region.
It is one of the seven Central Armed Police Forces of India, established in 1962 in the aftermath of the Sino-Indian War of 1962, Pharmacist job in ITBP; Pharmacy job in the Home Ministry; Pharmacist job under the central government
Post: Pharmacist
ITB Police Force invites online applications from Male & Female Indian * Citizens to fill up vacancies of Assistant Sub Inspector (Pharmacist) in Group ‘C’ (Non-Gazetted & Non-Ministerial) on a temporary basis likely to be permanent in ITB Police Force in Pay scale- Pay Level-5 in the Pay Matrix, Rs. 29,200-92,300/- (as per 7th CPC). Selected candidates will be liable to serve anywhere in India or abroad.
The applicants are advised to check their eligibility before applying so as to avoid disappointment at a later stage,
No of posts : 24 (UR-12, EWS-02, OBC-06, SC-03, ST -01)
Note:- (i) The vacancies are tentative and may increase or decrease without any notice. Any change in the number of vacancies will be intimated through the ITBPF Recruitment website
(ii) Application Fee:- Rs. 100/- (Rupees One Hundred Only). Fees are exempted for females, Ex-Servicemen, and candidates belonging to Scheduled Caste(SC) and Scheduled Tribe(ST) category.
(iii) 10% of vacancies of this ASI(Pharmacist) are reserved for Ex-Servicemen. ITBPF reserves the right to make changes in the sequence of the recruitment procedure after the publication of this advertisement.
ITBPF also reserves the right to cancel or postpone the recruitment at any stage due to administrative reasons.
Minimum educational and other essential qualifications
i) Pass the Senior Secondary Certificate (10+2) Examination with physics, chemistry and biology as subjects from a recognized Board or equivalent.
ii) Diploma in Pharmacy from any institution of or recognized by the Central or State Government.
iii) Registered as a Pharmacist under the Pharmacy Act 1948.
Age limit
Between 20 to 28 years (The upper age limit is relaxable for SC, ST, OBC, Ex-Servicemen and Govt. A servant in accordance with the instructions & orders issued by the Central Government from time to time.
Cut off date for determining the age will be 23rd November 2022 (23/11/2022) i.e. the last date for receipt of the online application.
Candidates should not have been born earlier than 24,h November 1994 and Later than 23rd November 2002.
GENERAL INSTRUCTIONS
(1) If candidates are found to indulge at any stage in any of the malpractices listed below during the conduct of recruitment or thereafter, their candidature for this recruitment will be cancelled
(a) Taking away any Examination related material such as OMR sheets, Rough Sheets, Answer Sheets etc. from the examination hall or passing it on to unauthorized persons during the conduct of the examination.
(b) Leaving the Examination Venue without prior permission of the invigilator.
(c) Assault, use of force, causing bodily harm, misbehaving, intimidating or threatening in any manner with the examination functionaries’ i.e. Supervisor, Invigilator, Security Guard or TTBPF representatives etc.
(d) Obstruct the conduct of the examination/ instigate other candidates not to take the examination.
(e) Making statements which are incorrect or false, suppressing material information, submitting fabricated documents, etc.
f) Obtaining support/ influence for his/ her candidature by any irregular or improper means in connection with his/ her candidature.
(g) Possession of Mobile Phone in either ‘switched on or ‘switched off mode.
(h) A person who is associated with the conduct of the examination in any manner, whatsoever.
(i) Damaging examination related infrastructure/ equipments.
(j) Appearing in the Exam with a forged Admit Card, identity proof, etc.
(k) Possession of firearms/ lethal weapons during the examination.
(1) Threatening/ intimidating examination functionaries with weapons/ fire arms.
(m) Using unfair means in the examination hall like copying from unauthorized sources such as written material on any paper or body parts, etc.
(n) Possession of Bluetooth Devices, spy cameras, and any other electronic gadgets in the examination hall.
(o) Impersonate/ Procuring impersonation by any person.
(p) Taking snapshots, making videos of question papers or examination material, labs, etc,
(q) Sharing examination terminal through remote desktop software/ Apps/ LAN/ WAN etc.
(r) Attempt to hack or manipulate examination servers, data and examination systems at any point before, during or after the examination.
Note:- The ITBPF may also report the matter to Police/Investigating Agencies etc., as deemed fit, for taking further necessary action.
(2) If deemed appropriate, the ITBPF may also report the matter to police/investigating agencies. Further, the ITBPF may also take appropriate action to get the matter examined by the concerned authorities/forensic experts etc.
(3) All candidates who have been called for PET, PST will bring a clear and legible printout of the online application form for purpose of identification else they will not be permitted to enter the venue. The printout will be retained by ITBP staff for office use.
(4) Candidates are to ensure to keep a sufficient number of same passport-size photos used by them in filling out the online application form.
The candidates are also advised to bring the same passport-size photos submitted with the online application form at all stages of recruitment.
(5) Verification of original documents will be conducted before the Practical Examination; therefore candidates are advised to confirm their eligibility in all respects to avoid any disappointment at a later stage.
(6) Admit cards to the eligible candidates will be issued online by mentioning the date and venue. Candidates have to download an online admit card from the ITBP recruitment website i.e. recruitmentitbpoIice.nic.in.
Therefore, candidates should provide a genuine and functional e-mail ID and Mobile number at the time of filling the online application form.
ITBP will not be responsible in case of non-receipt of admit card due to technical and other reasons.
(7) ITBP shall not be responsible for any damage/injury to the individual sustained during the course of the recruitment process.
(8) Candidates are advised to beware of touts or not to fall prey to unscrupulous elements. Recruitment in ITBP is totally transparent, fair and purely on the basis of the performance of the aspirants.
No candidate is required to pay any money in cash or otherwise, for recruitment in ITBPF except the nominal application fee. If someone approaches any candidate and asks for money or any other favour, they may report the matter to the recruitment board or the local police.
(9) ITBP will not be responsible for any power failure, electronic, internet-related problems, etc faced by the candidates while applying online.
(10) Candidates shall be required to serve in the Force for a minimum period of 10 years. If any person after joining the service wants to resign from the service before the expiry of 10 years, he/she is required to refund a sum equal to three months’ pay and allowances attached to the post or the cost of training imparted to him/her by the Force, whichever is higher.
(11) Selected candidates must complete Basic Training as well as any other courses prescribed by the Force from time to time.
(12) No correspondence will be entertained from ineligible candidates whose applications have been rejected.
03) Candidates belonging to the physically handicapped category are not eligible to apply for this examination.
(14) Any further information/notice with respect to the subject recruitment will be published on www.recruitmentitbnolice.nic.in onlv. Hence, all candidates are advised to log on to the above link from time to time.
(15) Candidates should come duly prepared for more than one day's stay under their own arrangements at the Recruitment Centre.
(16) No Travelling allowance (TA)/ Daily Allowance (DA) will be admissible for the journey up to the recruitment venue and back.
(17) Incomplete applications will be summarily rejected and no correspondence in this regard will be entertained.
(18) Change in a category will NOT be entertained at a later stage by ITBPF and the candidature of such candidate shall be canceled.
(19) No application received after the last date as mentioned above will be accepted.
(20) All disputes and differences, if any, will be subject to the jurisdiction of the courts within the territorial limits of Delhi only.
HOW TO APPLY AND BY WHICH DATE
a) Eligible and interested candidates must apply online at www.recruitment.itbpoIice.nic.in, the ITBPF website.
Candidates are advised to fill out the online application form after reading the instructions carefully and should provide a genuine and functional e-mail ID and Mobile number at the time of filling out the online application form.
Details, as required under various segments, should be mentioned clearly, correctly, and logically, As the applications need to be submitted online only, applications received offline shall not be considered and will be rejected summarily.
b) APPLICATION FEE & MODE OF PAYMENT - Male candidates belonging to
Unreserved(UR), Other Backward Class (OBC) and Economically Weaker Section(EWS) categories applying for recruitment to the post should pay Rs. 100/- (Rupees One hundred only) as application fee through the online payment gateway system on recruitment.itbpolice.nic.in. Candidates belonging to Scheduled Caste(SC), Scheduled Tribe(ST), Females and Ex-servicemen are exempted from paying the fee.
Note:-
i) Fee once paid will not be refunded under any circumstances.
ii) Fee paid by mode other than above will not be accepted and the applications
of such candidate will be rejected forthright and the payment made shall stand forfeited.
c) Candidates working in Central/State Government/ Autonomous/ Statutory Bodies/ Public Sector Undertaking etc. applied to the post of Assistant Sub Inspector (Pharmacist) are required to furnish a “No Objection Certificate” in original as per Annexure-IV issued by the employer at the time of verification of documents.
The candidature of candidates who fail to submit a “No Objection Certificate” at the time of verification of documents shall be summarily rejected.
d) Online application mode will be opened w.e.f. 25th October 2022 (25/10/2022) at 00:01 A.M. and will be closed on 23rd November 2022 (23/11/2022) at 11:59 P.M.
Last date: 23rd November 2022 (23/11/2022) at 11:59 P.M
Govt Job: For Pharmacy, Life Sciences candidates at PBTI – Pay Rs. 67,400 pm
Govt Job: Applications are invited for post of JRF at ICMR-NARI
Govt Job: For M.Pharm under Ministry of Health and Family Welfare
Govt Job: For Pharmacist under Public Service Commission
Govt Job: For B.Pharm, MSc as Technical Assistant at NICPR
Govt Job: For M.Pharm or MSc for Senior Research Fellow at…
https://thehealthmaster.com/2022/10/27/govt-job-for-the-post-of-pharmacists-at-itbp/
Thursday, October 27, 2022
Subscribe to:
Posts (Atom)